Contact Robert Melton, Esq. or submit a business inquiry online.
-
Reviewing Cyber Insurance During Renewal or Prior to an Annual Tabletop Exercise
- April 2, 2026
- Posted by: rob
- Category: Data Privacy & Cybersecurity
No Comments
-
AI Washing in Securities Disclosures: SEC Enforcement Risk for Public Companies
AI washing — overstating a company’s AI capabilities to investors — has become an active SEC enforcement priority. From the 2024 Delphia and Global Predictions actions to the 2025 Presto Automation case and criminal charges against Nate Inc., this post analyzes what the cases establish and how to build a legally defensible AI disclosure program.
September 27, 2026 Read more -
SEC Recordkeeping Rules and AI-Generated Content: What Financial Firms Must Retain
The SEC’s recordkeeping enforcement campaign cost financial institutions over $600 million in penalties — and AI-generated content faces the same analytical framework. This post explains what broker-dealers and investment advisers must retain under Rules 17a-4 and 204-2, and what a compliance audit should cover in 2026.
September 26, 2026 Read more -
AI in Drug Discovery: IP, Regulatory Validation, and Licensing Considerations
AI is transforming drug discovery, but it raises complex legal questions around patent inventorship, FDA regulatory validation, and licensing agreement structure. This post works through all three systematically for biotech companies, pharma licensors, and their counsel.
September 25, 2026 Read more -
AI and Biobank Consent: Why Historical Consent Forms Don’t Cover AI Training
Biobanks hold millions of samples collected under consent forms that predate AI — but pharmaceutical companies need that data for AI drug discovery training. This post examines the Common Rule and HIPAA consent gaps, the IP risks they create, and the remediation strategies institutions must deploy now.
September 24, 2026 Read more
